National Research Center "Kurchatov Institute", Moscow, 117545, Russia.
Biochemistry (Mosc). 2023 Sep;88(9):1338-1346. doi: 10.1134/S0006297923090134.
Using CRISPR/Cas9 system, the recipient strains K. phaffii VKPM Y-5013 (His phenotype) and K. phaffii VKPM Y-5014 (Leu phenotype) were derived from the K. phaffii VKPM Y-4287 strain, which has a high expression potential. Based on the developed recipient strains, markerless producers of heterologous proteins could be obtained. Efficiency of the gene inactivation with different variants of sgRNA ranged from 65 to 98% and from 15 to 72% for the HIS4 and LEU2 genes, respectively. The recipient strains retained growth characteristics of the parent strain and exhibited high expression potential, as estimated by the production of heterologous phytase from Citrobacter gillenii. Average productivity of the transformants based on the K. phaffii VKPM Y-5013 and K. phaffii VKPM Y-5014 strains was 2.1 and 2.0 times higher than productivity of the transformants of the commercial K. phaffii GS115 strain. Method for sequential integration of genetic material into genome of the K. phaffii VKPM Y-5013 strain was proposed. A highly effective multicopy markerless strain producing C. gillenii phytase was obtained.
利用 CRISPR/Cas9 系统,从具有高表达潜力的 K. phaffii VKPM Y-4287 菌株衍生出受体菌株 K. phaffii VKPM Y-5013(His 表型)和 K. phaffii VKPM Y-5014(Leu 表型)。基于开发的受体菌株,可以获得异源蛋白的无标记生产者。不同 sgRNA 变体的基因失活效率范围为 His4 基因的 65%至 98%,Leu2 基因的 15%至 72%。受体菌株保留了亲本菌株的生长特性,并表现出高表达潜力,这可以通过来自柠檬酸杆菌的异源植酸酶的生产来估计。基于 K. phaffii VKPM Y-5013 和 K. phaffii VKPM Y-5014 菌株的转化体的平均生产力比商业 K. phaffii GS115 菌株的转化体的生产力高 2.1 和 2.0 倍。提出了将遗传物质顺序整合到 K. phaffii VKPM Y-5013 菌株基因组中的方法。获得了产 C. gillenii 植酸酶的高效多拷贝无标记菌株。